$59.70
arrow_drop_up2.05%Key Stats | |
---|---|
Open | $56.76 |
Prev. Close | $57.38 |
EPS | -5.40 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 56.63 | 57.93 |
52 Week Range | 25.98 | 110.25 |
Ratios | |
---|---|
EPS | -5.40 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics to Participate in June Investor Conferences
Cytokinetics Announces Closing of Public Offering of Common Stock
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.